Global Dactinomycin Market Insights and Forecast to 2028

Dactinomycin is a mixture of Streptomyces chrysomallus, mainly composed of C1, C2, C3 and D.Red or orange-yellow crystalline powder of madder.Soluble in ethanol, acetone and benzene.Its effect is similar to that of actinomycin, and it has a wide antitumor spectrum.In addition, also has the strong resistance bacteria, fungi and viruses.It is mainly used for Hodgkin's disease, nephroblastoma and leukemia in children.The toxic and side effects are similar to those of actinomycin, mainly myelosuppression and gastrointestinal reactions.Advanced malignant tumors, low red and white blood cells and pregnant women are contraindicated.

Market Analysis and Insights: Global Dactinomycin Market

The global Dactinomycin market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Fully considering the economic change by this health crisis, Injection accounting for % of the Dactinomycin global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Alkylating Agent segment is altered to an % CAGR throughout this forecast period.

China Dactinomycin market size is valued at US$ million in 2021, while the North America and Europe Dactinomycin are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Dactinomycin landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Dactinomycin market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Dactinomycin market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Dactinomycin market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Dactinomycin market.

Global Dactinomycin Scope and Market Size

Dactinomycin market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Dactinomycin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Injection

Implants

Alkylating Agent

Hormone

Plant Medicine

AstraZeneca

GSK

Recordati Rare Diseases

Lundbeck

Merck

Prasco Laboratories

X-GEN Pharmaceuticals

Mylan Institutional

Bedford Pharmaceuticals

HISUN

Hainan Jinrui Pharmaceutical

Qilu Pharmaceutical

Shanghai Zhongke Pharmaceutical

Shanghai Xinya Pharmaceutical

Nantong Xinhe Biotechnology

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Dactinomycin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Injection

1.2.3 Implants

1.3 Market by Application

1.3.1 Global Dactinomycin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Alkylating Agent

1.3.3 Hormone

1.3.4 Plant Medicine

1.4 Study Objectives

1.5 Years Considered

2.1 Global Dactinomycin Market Perspective (2017-2028)

2.2 Dactinomycin Growth Trends by Region

2.2.1 Dactinomycin Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Dactinomycin Historic Market Size by Region (2017-2022)

2.2.3 Dactinomycin Forecasted Market Size by Region (2023-2028)

2.3 Dactinomycin Market Dynamics

2.3.1 Dactinomycin Industry Trends

2.3.2 Dactinomycin Market Drivers

2.3.3 Dactinomycin Market Challenges

2.3.4 Dactinomycin Market Restraints

3.1 Global Top Dactinomycin Players by Revenue

3.1.1 Global Top Dactinomycin Players by Revenue (2017-2022)

3.1.2 Global Dactinomycin Revenue Market Share by Players (2017-2022)

3.2 Global Dactinomycin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Dactinomycin Revenue

3.4 Global Dactinomycin Market Concentration Ratio

3.4.1 Global Dactinomycin Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Dactinomycin Revenue in 2021

3.5 Dactinomycin Key Players Head office and Area Served

3.6 Key Players Dactinomycin Product Solution and Service

3.7 Date of Enter into Dactinomycin Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Dactinomycin Historic Market Size by Type (2017-2022)

4.2 Global Dactinomycin Forecasted Market Size by Type (2023-2028)

5.1 Global Dactinomycin Historic Market Size by Application (2017-2022)

5.2 Global Dactinomycin Forecasted Market Size by Application (2023-2028)

6.1 North America Dactinomycin Market Size (2017-2028)

6.2 North America Dactinomycin Market Size by Type

6.2.1 North America Dactinomycin Market Size by Type (2017-2022)

6.2.2 North America Dactinomycin Market Size by Type (2023-2028)

6.2.3 North America Dactinomycin Market Share by Type (2017-2028)

6.3 North America Dactinomycin Market Size by Application

6.3.1 North America Dactinomycin Market Size by Application (2017-2022)

6.3.2 North America Dactinomycin Market Size by Application (2023-2028)

6.3.3 North America Dactinomycin Market Share by Application (2017-2028)

6.4 North America Dactinomycin Market Size by Country

6.4.1 North America Dactinomycin Market Size by Country (2017-2022)

6.4.2 North America Dactinomycin Market Size by Country (2023-2028)

6.4.3 U.S.

6.4.4 Canada

7.1 Europe Dactinomycin Market Size (2017-2028)

7.2 Europe Dactinomycin Market Size by Type

7.2.1 Europe Dactinomycin Market Size by Type (2017-2022)

7.2.2 Europe Dactinomycin Market Size by Type (2023-2028)

7.2.3 Europe Dactinomycin Market Share by Type (2017-2028)

7.3 Europe Dactinomycin Market Size by Application

7.3.1 Europe Dactinomycin Market Size by Application (2017-2022)

7.3.2 Europe Dactinomycin Market Size by Application (2023-2028)

7.3.3 Europe Dactinomycin Market Share by Application (2017-2028)

7.4 Europe Dactinomycin Market Size by Country

7.4.1 Europe Dactinomycin Market Size by Country (2017-2022)

7.4.2 Europe Dactinomycin Market Size by Country (2023-2028)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8.1 Asia-Pacific Dactinomycin Market Size (2017-2028)

8.2 Asia-Pacific Dactinomycin Market Size by Type

8.2.1 Asia-Pacific Dactinomycin Market Size by Type (2017-2022)

8.2.2 Asia-Pacific Dactinomycin Market Size by Type (2023-2028)

8.2.3 Asia-Pacific Dactinomycin Market Share by Type (2017-2028)

8.3 Asia-Pacific Dactinomycin Market Size by Application

8.3.1 Asia-Pacific Dactinomycin Market Size by Application (2017-2022)

8.3.2 Asia-Pacific Dactinomycin Market Size by Application (2023-2028)

8.3.3 Asia-Pacific Dactinomycin Market Share by Application (2017-2028)

8.4 Asia-Pacific Dactinomycin Market Size by Region

8.4.1 Asia-Pacific Dactinomycin Market Size by Region (2017-2022)

8.4.2 Asia-Pacific Dactinomycin Market Size by Region (2023-2028)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9.1 Latin America Dactinomycin Market Size (2017-2028)

9.2 Latin America Dactinomycin Market Size by Type

9.2.1 Latin America Dactinomycin Market Size by Type (2017-2022)

9.2.2 Latin America Dactinomycin Market Size by Type (2023-2028)

9.2.3 Latin America Dactinomycin Market Share by Type (2017-2028)

9.3 Latin America Dactinomycin Market Size by Application

9.3.1 Latin America Dactinomycin Market Size by Application (2017-2022)

9.3.2 Latin America Dactinomycin Market Size by Application (2023-2028)

9.3.3 Latin America Dactinomycin Market Share by Application (2017-2028)

9.4 Latin America Dactinomycin Market Size by Country

9.4.1 Latin America Dactinomycin Market Size by Country (2017-2022)

9.4.2 Latin America Dactinomycin Market Size by Country (2023-2028)

9.4.3 Mexico

9.4.4 Brazil

10.1 Middle East & Africa Dactinomycin Market Size (2017-2028)

10.2 Middle East & Africa Dactinomycin Market Size by Type

10.2.1 Middle East & Africa Dactinomycin Market Size by Type (2017-2022)

10.2.2 Middle East & Africa Dactinomycin Market Size by Type (2023-2028)

10.2.3 Middle East & Africa Dactinomycin Market Share by Type (2017-2028)

10.3 Middle East & Africa Dactinomycin Market Size by Application

10.3.1 Middle East & Africa Dactinomycin Market Size by Application (2017-2022)

10.3.2 Middle East & Africa Dactinomycin Market Size by Application (2023-2028)

10.3.3 Middle East & Africa Dactinomycin Market Share by Application (2017-2028)

10.4 Middle East & Africa Dactinomycin Market Size by Country

10.4.1 Middle East & Africa Dactinomycin Market Size by Country (2017-2022)

10.4.2 Middle East & Africa Dactinomycin Market Size by Country (2023-2028)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11.1 AstraZeneca

11.1.1 AstraZeneca Company Details

11.1.2 AstraZeneca Business Overview

11.1.3 AstraZeneca Dactinomycin Introduction

11.1.4 AstraZeneca Revenue in Dactinomycin Business (2017-2022)

11.1.5 AstraZeneca Recent Developments

11.2 GSK

11.2.1 GSK Company Details

11.2.2 GSK Business Overview

11.2.3 GSK Dactinomycin Introduction

11.2.4 GSK Revenue in Dactinomycin Business (2017-2022)

11.2.5 GSK Recent Developments

11.3 Recordati Rare Diseases

11.3.1 Recordati Rare Diseases Company Details

11.3.2 Recordati Rare Diseases Business Overview

11.3.3 Recordati Rare Diseases Dactinomycin Introduction

11.3.4 Recordati Rare Diseases Revenue in Dactinomycin Business (2017-2022)

11.3.5 Recordati Rare Diseases Recent Developments

11.4 Lundbeck

11.4.1 Lundbeck Company Details

11.4.2 Lundbeck Business Overview

11.4.3 Lundbeck Dactinomycin Introduction

11.4.4 Lundbeck Revenue in Dactinomycin Business (2017-2022)

11.4.5 Lundbeck Recent Developments

11.5 Merck

11.5.1 Merck Company Details

11.5.2 Merck Business Overview

11.5.3 Merck Dactinomycin Introduction

11.5.4 Merck Revenue in Dactinomycin Business (2017-2022)

11.5.5 Merck Recent Developments

11.6 Prasco Laboratories

11.6.1 Prasco Laboratories Company Details

11.6.2 Prasco Laboratories Business Overview

11.6.3 Prasco Laboratories Dactinomycin Introduction

11.6.4 Prasco Laboratories Revenue in Dactinomycin Business (2017-2022)

11.6.5 Prasco Laboratories Recent Developments

11.7 X-GEN Pharmaceuticals

11.7.1 X-GEN Pharmaceuticals Company Details

11.7.2 X-GEN Pharmaceuticals Business Overview

11.7.3 X-GEN Pharmaceuticals Dactinomycin Introduction

11.7.4 X-GEN Pharmaceuticals Revenue in Dactinomycin Business (2017-2022)

11.7.5 X-GEN Pharmaceuticals Recent Developments

11.8 Mylan Institutional

11.8.1 Mylan Institutional Company Details

11.8.2 Mylan Institutional Business Overview

11.8.3 Mylan Institutional Dactinomycin Introduction

11.8.4 Mylan Institutional Revenue in Dactinomycin Business (2017-2022)

11.8.5 Mylan Institutional Recent Developments

11.9 Bedford Pharmaceuticals

11.9.1 Bedford Pharmaceuticals Company Details

11.9.2 Bedford Pharmaceuticals Business Overview

11.9.3 Bedford Pharmaceuticals Dactinomycin Introduction

11.9.4 Bedford Pharmaceuticals Revenue in Dactinomycin Business (2017-2022)

11.9.5 Bedford Pharmaceuticals Recent Developments

11.10 HISUN

11.10.1 HISUN Company Details

11.10.2 HISUN Business Overview

11.10.3 HISUN Dactinomycin Introduction

11.10.4 HISUN Revenue in Dactinomycin Business (2017-2022)

11.10.5 HISUN Recent Developments

11.11 Hainan Jinrui Pharmaceutical

11.11.1 Hainan Jinrui Pharmaceutical Company Details

11.11.2 Hainan Jinrui Pharmaceutical Business Overview

11.11.3 Hainan Jinrui Pharmaceutical Dactinomycin Introduction

11.11.4 Hainan Jinrui Pharmaceutical Revenue in Dactinomycin Business (2017-2022)

11.11.5 Hainan Jinrui Pharmaceutical Recent Developments

11.12 Qilu Pharmaceutical

11.12.1 Qilu Pharmaceutical Company Details

11.12.2 Qilu Pharmaceutical Business Overview

11.12.3 Qilu Pharmaceutical Dactinomycin Introduction

11.12.4 Qilu Pharmaceutical Revenue in Dactinomycin Business (2017-2022)

11.12.5 Qilu Pharmaceutical Recent Developments

11.13 Shanghai Zhongke Pharmaceutical

11.13.1 Shanghai Zhongke Pharmaceutical Company Details

11.13.2 Shanghai Zhongke Pharmaceutical Business Overview

11.13.3 Shanghai Zhongke Pharmaceutical Dactinomycin Introduction

11.13.4 Shanghai Zhongke Pharmaceutical Revenue in Dactinomycin Business (2017-2022)

11.13.5 Shanghai Zhongke Pharmaceutical Recent Developments

11.14 Shanghai Xinya Pharmaceutical

11.14.1 Shanghai Xinya Pharmaceutical Company Details

11.14.2 Shanghai Xinya Pharmaceutical Business Overview

11.14.3 Shanghai Xinya Pharmaceutical Dactinomycin Introduction

11.14.4 Shanghai Xinya Pharmaceutical Revenue in Dactinomycin Business (2017-2022)

11.14.5 Shanghai Xinya Pharmaceutical Recent Developments

11.15 Nantong Xinhe Biotechnology

11.15.1 Nantong Xinhe Biotechnology Company Details

11.15.2 Nantong Xinhe Biotechnology Business Overview

11.15.3 Nantong Xinhe Biotechnology Dactinomycin Introduction

11.15.4 Nantong Xinhe Biotechnology Revenue in Dactinomycin Business (2017-2022)

11.15.5 Nantong Xinhe Biotechnology Recent Developments

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer

List of Tables

    Table 1. Global Dactinomycin Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028

    Table 2. Key Players of Injection

    Table 3. Key Players of Implants

    Table 4. Global Dactinomycin Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028

    Table 5. Global Dactinomycin Market Size by Region (US$ Million): 2017 VS 2021 VS 2028

    Table 6. Global Dactinomycin Market Size by Region (2017-2022) & (US$ Million)

    Table 7. Global Dactinomycin Market Share by Region (2017-2022)

    Table 8. Global Dactinomycin Forecasted Market Size by Region (2023-2028) & (US$ Million)

    Table 9. Global Dactinomycin Market Share by Region (2023-2028)

    Table 10. Dactinomycin Market Trends

    Table 11. Dactinomycin Market Drivers

    Table 12. Dactinomycin Market Challenges

    Table 13. Dactinomycin Market Restraints

    Table 14. Global Dactinomycin Revenue by Players (2017-2022) & (US$ Million)

    Table 15. Global Dactinomycin Revenue Share by Players (2017-2022)

    Table 16. Global Top Dactinomycin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dactinomycin as of 2021)

    Table 17. Ranking of Global Top Dactinomycin Companies by Revenue (US$ Million) in 2021

    Table 18. Global 5 Largest Players Market Share by Dactinomycin Revenue (CR5 and HHI) & (2017-2022)

    Table 19. Key Players Headquarters and Area Served

    Table 20. Key Players Dactinomycin Product Solution and Service

    Table 21. Date of Enter into Dactinomycin Market

    Table 22. Mergers & Acquisitions, Expansion Plans

    Table 23. Global Dactinomycin Market Size by Type (2017-2022) & (US$ Million)

    Table 24. Global Dactinomycin Revenue Market Share by Type (2017-2022)

    Table 25. Global Dactinomycin Forecasted Market Size by Type (2023-2028) & (US$ Million)

    Table 26. Global Dactinomycin Revenue Market Share by Type (2023-2028)

    Table 27. Global Dactinomycin Market Size by Application (2017-2022) & (US$ Million)

    Table 28. Global Dactinomycin Revenue Share by Application (2017-2022)

    Table 29. Global Dactinomycin Forecasted Market Size by Application (2023-2028) & (US$ Million)

    Table 30. Global Dactinomycin Revenue Share by Application (2023-2028)

    Table 31. North America Dactinomycin Market Size by Type (2017-2022) & (US$ Million)

    Table 32. North America Dactinomycin Market Size by Type (2023-2028) & (US$ Million)

    Table 33. North America Dactinomycin Market Size by Application (2017-2022) & (US$ Million)

    Table 34. North America Dactinomycin Market Size by Application (2023-2028) & (US$ Million)

    Table 35. North America Dactinomycin Market Size by Country (2017-2022) & (US$ Million)

    Table 36. North America Dactinomycin Market Size by Country (2023-2028) & (US$ Million)

    Table 37. Europe Dactinomycin Market Size by Type (2017-2022) & (US$ Million)

    Table 38. Europe Dactinomycin Market Size by Type (2023-2028) & (US$ Million)

    Table 39. Europe Dactinomycin Market Size by Application (2017-2022) & (US$ Million)

    Table 40. Europe Dactinomycin Market Size by Application (2023-2028) & (US$ Million)

    Table 41. Europe Dactinomycin Market Size by Country (2017-2022) & (US$ Million)

    Table 42. Europe Dactinomycin Market Size by Country (2023-2028) & (US$ Million)

    Table 43. Asia Pacific Dactinomycin Market Size by Type (2017-2022) & (US$ Million)

    Table 44. Asia Pacific Dactinomycin Market Size by Type (2023-2028) & (US$ Million)

    Table 45. Asia Pacific Dactinomycin Market Size by Application (2017-2022) & (US$ Million)

    Table 46. Asia Pacific Dactinomycin Market Size by Application (2023-2028) & (US$ Million)

    Table 47. Asia Pacific Dactinomycin Market Size by Region (2017-2022) & (US$ Million)

    Table 48. Asia Pacific Dactinomycin Market Size by Region (2023-2028) & (US$ Million)

    Table 49. Latin America Dactinomycin Market Size by Type (2017-2022) & (US$ Million)

    Table 50. Latin America Dactinomycin Market Size by Type (2023-2028) & (US$ Million)

    Table 51. Latin America Dactinomycin Market Size by Application (2017-2022) & (US$ Million)

    Table 52. Latin America Dactinomycin Market Size by Application (2023-2028) & (US$ Million)

    Table 53. Latin America Dactinomycin Market Size by Country (2017-2022) & (US$ Million)

    Table 54. Latin America Dactinomycin Market Size by Country (2023-2028) & (US$ Million)

    Table 55. Middle East and Africa Dactinomycin Market Size by Type (2017-2022) & (US$ Million)

    Table 56. Middle East and Africa Dactinomycin Market Size by Type (2023-2028) & (US$ Million)

    Table 57. Middle East and Africa Dactinomycin Market Size by Application (2017-2022) & (US$ Million)

    Table 58. Middle East and Africa Dactinomycin Market Size by Application (2023-2028) & (US$ Million)

    Table 59. Middle East and Africa Dactinomycin Market Size by Country (2017-2022) & (US$ Million)

    Table 60. Middle East and Africa Dactinomycin Market Size by Country (2023-2028) & (US$ Million)

    Table 61. AstraZeneca Company Details

    Table 62. AstraZeneca Business Overview

    Table 63. AstraZeneca Dactinomycin Product

    Table 64. AstraZeneca Revenue in Dactinomycin Business (2017-2022) & (US$ Million)

    Table 65. AstraZeneca Recent Developments

    Table 66. GSK Company Details

    Table 67. GSK Business Overview

    Table 68. GSK Dactinomycin Product

    Table 69. GSK Revenue in Dactinomycin Business (2017-2022) & (US$ Million)

    Table 70. GSK Recent Developments

    Table 71. Recordati Rare Diseases Company Details

    Table 72. Recordati Rare Diseases Business Overview

    Table 73. Recordati Rare Diseases Dactinomycin Product

    Table 74. Recordati Rare Diseases Revenue in Dactinomycin Business (2017-2022) & (US$ Million)

    Table 75. Recordati Rare Diseases Recent Developments

    Table 76. Lundbeck Company Details

    Table 77. Lundbeck Business Overview

    Table 78. Lundbeck Dactinomycin Product

    Table 79. Lundbeck Revenue in Dactinomycin Business (2017-2022) & (US$ Million)

    Table 80. Lundbeck Recent Developments

    Table 81. Merck Company Details

    Table 82. Merck Business Overview

    Table 83. Merck Dactinomycin Product

    Table 84. Merck Revenue in Dactinomycin Business (2017-2022) & (US$ Million)

    Table 85. Merck Recent Developments

    Table 86. Prasco Laboratories Company Details

    Table 87. Prasco Laboratories Business Overview

    Table 88. Prasco Laboratories Dactinomycin Product

    Table 89. Prasco Laboratories Revenue in Dactinomycin Business (2017-2022) & (US$ Million)

    Table 90. Prasco Laboratories Recent Developments

    Table 91. X-GEN Pharmaceuticals Company Details

    Table 92. X-GEN Pharmaceuticals Business Overview

    Table 93. X-GEN Pharmaceuticals Dactinomycin Product

    Table 94. X-GEN Pharmaceuticals Revenue in Dactinomycin Business (2017-2022) & (US$ Million)

    Table 95. X-GEN Pharmaceuticals Recent Developments

    Table 96. Mylan Institutional Company Details

    Table 97. Mylan Institutional Business Overview

    Table 98. Mylan Institutional Dactinomycin Product

    Table 99. Mylan Institutional Revenue in Dactinomycin Business (2017-2022) & (US$ Million)

    Table 100. Mylan Institutional Recent Developments

    Table 101. Bedford Pharmaceuticals Company Details

    Table 102. Bedford Pharmaceuticals Business Overview

    Table 103. Bedford Pharmaceuticals Dactinomycin Product

    Table 104. Bedford Pharmaceuticals Revenue in Dactinomycin Business (2017-2022) & (US$ Million)

    Table 105. Bedford Pharmaceuticals Recent Developments

    Table 106. HISUN Company Details

    Table 107. HISUN Business Overview

    Table 108. HISUN Dactinomycin Product

    Table 109. HISUN Revenue in Dactinomycin Business (2017-2022) & (US$ Million)

    Table 110. HISUN Recent Developments

    Table 111. Hainan Jinrui Pharmaceutical Company Details

    Table 112. Hainan Jinrui Pharmaceutical Business Overview

    Table 113. Hainan Jinrui Pharmaceutical Dactinomycin Product

    Table 114. Hainan Jinrui Pharmaceutical Revenue in Dactinomycin Business (2017-2022) & (US$ Million)

    Table 115. Hainan Jinrui Pharmaceutical Recent Developments

    Table 116. Qilu Pharmaceutical Company Details

    Table 117. Qilu Pharmaceutical Business Overview

    Table 118. Qilu Pharmaceutical Dactinomycin Product

    Table 119. Qilu Pharmaceutical Revenue in Dactinomycin Business (2017-2022) & (US$ Million)

    Table 120. Qilu Pharmaceutical Recent Developments

    Table 121. Shanghai Zhongke Pharmaceutical Company Details

    Table 122. Shanghai Zhongke Pharmaceutical Business Overview

    Table 123. Shanghai Zhongke Pharmaceutical Dactinomycin Product

    Table 124. Shanghai Zhongke Pharmaceutical Revenue in Dactinomycin Business (2017-2022) & (US$ Million)

    Table 125. Shanghai Zhongke Pharmaceutical Recent Developments

    Table 126. Shanghai Xinya Pharmaceutical Company Details

    Table 127. Shanghai Xinya Pharmaceutical Business Overview

    Table 128. Shanghai Xinya Pharmaceutical Dactinomycin Product

    Table 129. Shanghai Xinya Pharmaceutical Revenue in Dactinomycin Business (2017-2022) & (US$ Million)

    Table 130. Shanghai Xinya Pharmaceutical Recent Developments

    Table 131. Nantong Xinhe Biotechnology Company Details

    Table 132. Nantong Xinhe Biotechnology Business Overview

    Table 133. Nantong Xinhe Biotechnology Dactinomycin Product

    Table 134. Nantong Xinhe Biotechnology Revenue in Dactinomycin Business (2017-2022) & (US$ Million)

    Table 135. Nantong Xinhe Biotechnology Recent Developments

    Table 136. Research Programs/Design for This Report

    Table 137. Key Data Information from Secondary Sources

    Table 138. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Dactinomycin Market Share by Type: 2021 VS 2028

    Figure 2. Injection Features

    Figure 3. Implants Features

    Figure 4. Global Dactinomycin Market Share by Application: 2021 VS 2028

    Figure 5. Alkylating Agent Case Studies

    Figure 6. Hormone Case Studies

    Figure 7. Plant Medicine Case Studies

    Figure 8. Dactinomycin Report Years Considered

    Figure 9. Global Dactinomycin Market Size (US$ Million), Year-over-Year: 2017-2028

    Figure 10. Global Dactinomycin Market Size, (US$ Million), 2017 VS 2021 VS 2028

    Figure 11. Global Dactinomycin Market Share by Region: 2021 VS 2028

    Figure 12. Global Dactinomycin Market Share by Players in 2021

    Figure 13. Global Top Dactinomycin Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dactinomycin as of 2021)

    Figure 14. The Top 10 and 5 Players Market Share by Dactinomycin Revenue in 2021

    Figure 15. North America Dactinomycin Market Size YoY (2017-2028) & (US$ Million)

    Figure 16. North America Dactinomycin Market Size Market Share by Type (2017-2028)

    Figure 17. North America Dactinomycin Market Size Market Share by Application (2017-2028)

    Figure 18. North America Dactinomycin Market Size Share by Country (2017-2028)

    Figure 19. United States Dactinomycin Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 20. Canada Dactinomycin Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 21. Europe Dactinomycin Market Size YoY (2017-2028) & (US$ Million)

    Figure 22. Europe Dactinomycin Market Size Market Share by Type (2017-2028)

    Figure 23. Europe Dactinomycin Market Size Market Share by Application (2017-2028)

    Figure 24. Europe Dactinomycin Market Size Share by Country (2017-2028)

    Figure 25. Germany Dactinomycin Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 26. France Dactinomycin Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 27. U.K. Dactinomycin Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 28. Italy Dactinomycin Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 29. Russia Dactinomycin Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 30. Nordic Countries Dactinomycin Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 31. Asia-Pacific Dactinomycin Market Size YoY (2017-2028) & (US$ Million)

    Figure 32. Asia Pacific Dactinomycin Market Size Market Share by Type (2017-2028)

    Figure 33. Asia Pacific Dactinomycin Market Size Market Share by Application (2017-2028)

    Figure 34. Asia Pacific Dactinomycin Market Size Share by Region (2017-2028)

    Figure 35. China Dactinomycin Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 36. Japan Dactinomycin Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 37. South Korea Dactinomycin Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 38. Southeast Asia Dactinomycin Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 39. India Dactinomycin Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 40. Australia Dactinomycin Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

    Figure 41. Latin America Dactinomycin Market Size YoY (2017-2028) & (US$ Million)

    Figure 42. Latin America Dactinomycin Market Size Market Share by Type (2017-2028)

    Figure 43. Latin America Dactinomycin Market Size Market Share by Application (2017-2028)

    Figure 44. Latin America Dactinomycin Market Size Share by Country (2017-2028)

    Figure 45. Mexico Dactinomycin Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 46. Brazil Dactinomycin Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 47. Middle East & Africa Dactinomycin Market Size YoY (2017-2028) & (US$ Million)

    Figure 48. Middle East and Africa Dactinomycin Market Size Market Share by Type (2017-2028)

    Figure 49. Middle East and Africa Dactinomycin Market Size Market Share by Application (2017-2028)

    Figure 50. Middle East and Africa Dactinomycin Market Size Share by Country (2017-2028)

    Figure 51. Turkey Dactinomycin Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 52. Saudi Arabia Dactinomycin Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 53. UAE Dactinomycin Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 54. AstraZeneca Revenue Growth Rate in Dactinomycin Business (2017-2022)

    Figure 55. GSK Revenue Growth Rate in Dactinomycin Business (2017-2022)

    Figure 56. Recordati Rare Diseases Revenue Growth Rate in Dactinomycin Business (2017-2022)

    Figure 57. Lundbeck Revenue Growth Rate in Dactinomycin Business (2017-2022)

    Figure 58. Merck Revenue Growth Rate in Dactinomycin Business (2017-2022)

    Figure 59. Prasco Laboratories Revenue Growth Rate in Dactinomycin Business (2017-2022)

    Figure 60. X-GEN Pharmaceuticals Revenue Growth Rate in Dactinomycin Business (2017-2022)

    Figure 61. Mylan Institutional Revenue Growth Rate in Dactinomycin Business (2017-2022)

    Figure 62. Bedford Pharmaceuticals Revenue Growth Rate in Dactinomycin Business (2017-2022)

    Figure 63. HISUN Revenue Growth Rate in Dactinomycin Business (2017-2022)

    Figure 64. Hainan Jinrui Pharmaceutical Revenue Growth Rate in Dactinomycin Business (2017-2022)

    Figure 65. Qilu Pharmaceutical Revenue Growth Rate in Dactinomycin Business (2017-2022)

    Figure 66. Shanghai Zhongke Pharmaceutical Revenue Growth Rate in Dactinomycin Business (2017-2022)

    Figure 67. Shanghai Xinya Pharmaceutical Revenue Growth Rate in Dactinomycin Business (2017-2022)

    Figure 68. Nantong Xinhe Biotechnology Revenue Growth Rate in Dactinomycin Business (2017-2022)

    Figure 69. Bottom-up and Top-down Approaches for This Report

    Figure 70. Data Triangulation

    Figure 71. Key Executives Interviewed